195 related articles for article (PubMed ID: 23511135)
1. Effect of host defenses on Clostridium difficile toxin-induced intestinal barrier injury.
Olson A; Diebel LN; Liberati DM
J Trauma Acute Care Surg; 2013 Apr; 74(4):983-89; discussion 989-90. PubMed ID: 23511135
[TBL] [Abstract][Full Text] [Related]
2. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
Olson A; Diebel LN; Liberati DM
J Trauma Acute Care Surg; 2014 Oct; 77(4):570-5; discussion 576. PubMed ID: 25250596
[TBL] [Abstract][Full Text] [Related]
3. Reinforcement of the intestinal mucus layer protects against Clostridium difficile intestinal injury in vitro.
Diebel LN; Liberati DM
J Am Coll Surg; 2014 Sep; 219(3):460-8. PubMed ID: 25067805
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylcholine and the intestinal mucus layer: in vitro efficacy against Clostridium difficile-associated polymorphonuclear neutrophil activation.
Olson A; Diebel LN; Liberati DM
Am J Surg; 2015 Mar; 209(3):493-7. PubMed ID: 25595713
[TBL] [Abstract][Full Text] [Related]
5. Binding of Clostridium difficile toxin A to human milk secretory component.
Dallas SD; Rolfe RD
J Med Microbiol; 1998 Oct; 47(10):879-88. PubMed ID: 9788811
[TBL] [Abstract][Full Text] [Related]
6. Estrogen modulates intestinal mucus physiochemical properties and protects against oxidant injury.
Diebel ME; Diebel LN; Manke CW; Liberati DM
J Trauma Acute Care Surg; 2015 Jan; 78(1):94-9. PubMed ID: 25539208
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile toxin A. Interactions with mucus and early sequential histopathologic effects in rabbit small intestine.
Lima AA; Innes DJ; Chadee K; Lyerly DM; Wilkins TD; Guerrant RL
Lab Invest; 1989 Oct; 61(4):419-25. PubMed ID: 2507823
[TBL] [Abstract][Full Text] [Related]
8. Human intestinal epithelial response(s) to Clostridium difficile.
Jafari NV; Allan E; Bajaj-Elliott M
Methods Mol Biol; 2010; 646():135-46. PubMed ID: 20597007
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of varying concentrations of clostridium difficile toxin A on epithelial barrier function and expression of cytokines.
Johal SS; Solomon K; Dodson S; Borriello SP; Mahida YR
J Infect Dis; 2004 Jun; 189(11):2110-9. PubMed ID: 15143480
[TBL] [Abstract][Full Text] [Related]
10. T-cell cytokines affect mucosal immunoglobulin A transport.
Amin PB; Diebel LN; Liberati DM
Am J Surg; 2007 Jul; 194(1):128-33. PubMed ID: 17560924
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of Clostridium difficile toxin-induced damage to epithelial barrier by ecto-5'-nucleotidase (CD73) and adenosine receptor signaling.
Schenck LP; Hirota SA; Hirota CL; Boasquevisque P; Tulk SE; Li Y; Wadhwani A; Doktorchik CT; Macnaughton WK; Beck PL; MacDonald JA
Neurogastroenterol Motil; 2013 Jun; 25(6):e441-53. PubMed ID: 23600886
[TBL] [Abstract][Full Text] [Related]
12. Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical.
Canny G; Drudy D; Macmathuna P; O'farrelly C; Baird AW
Life Sci; 2006 Jan; 78(9):920-5. PubMed ID: 16185718
[TBL] [Abstract][Full Text] [Related]
13. The American Cockroach Peptide Periplanetasin-2 Blocks
Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
[No Abstract] [Full Text] [Related]
14. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
[TBL] [Abstract][Full Text] [Related]
15. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.
Geric B; Carman RJ; Rupnik M; Genheimer CW; Sambol SP; Lyerly DM; Gerding DN; Johnson S
J Infect Dis; 2006 Apr; 193(8):1143-50. PubMed ID: 16544255
[TBL] [Abstract][Full Text] [Related]
16. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
[No Abstract] [Full Text] [Related]
17. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
Feltis BA; Garni RM; Wells CL
J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes.
Feltis BA; Wiesner SM; Kim AS; Erlandsen SL; Lyerly DL; Wilkins TD; Wells CL
Shock; 2000 Dec; 14(6):629-34. PubMed ID: 11131913
[TBL] [Abstract][Full Text] [Related]
19. NF-kappa B activation pathway is essential for the chemokine expression in intestinal epithelial cells stimulated with Clostridium difficile toxin A.
Kim JM; Lee JY; Yoon YM; Oh YK; Youn J; Kim YJ
Scand J Immunol; 2006 Jun; 63(6):453-60. PubMed ID: 16764699
[TBL] [Abstract][Full Text] [Related]
20. The attachment, internalization, and time-dependent, intracellular distribution of Clostridium difficile toxin A in porcine intestinal explants.
Keel MK; Songer JG
Vet Pathol; 2011 Mar; 48(2):369-80. PubMed ID: 20861504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
